tetradecanoylphorbol acetate has been researched along with bb 2116 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couet, J; Hai, MT; Jolivet, A; Milgrom, E; Misrahi, M; Sar, S | 1 |
| Dong, J; Wiley, HS | 1 |
| Dietrich, S; Hansen, HP; Kisseleva, T; Lange, HH; Lemke, H; Mentlein, R; Mokros, T; Murphy, G | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and bb 2116
| Article | Year |
|---|---|
Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Endocytosis; Extracellular Matrix; Humans; Hydroxamic Acids; Kinetics; L Cells; Lysosomes; Macromolecular Substances; Metalloendopeptidases; Mice; Protease Inhibitors; Receptors, Thyrotropin; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thyroid Gland; Transfection | 1996 |
Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains.
Topics: Biological Transport; Calcimycin; Endocytosis; Epidermal Growth Factor; ErbB Receptors; Heparin-binding EGF-like Growth Factor; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Ligands; Metalloendopeptidases; Peptide Fragments; Protein Engineering; Recombinant Proteins; Tetradecanoylphorbol Acetate | 2000 |
CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.
Topics: ADAM Proteins; ADAM17 Protein; Cell Membrane; Cells, Cultured; Humans; Hydrolysis; Hydroxamic Acids; Ki-1 Antigen; Lymphocytes; Lymphoma; Metalloendopeptidases; Recombinant Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-3; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |